0

Cardiology Collection
 141-160 of 387 Articles
ACP Journal Club |  20 November 2012
Review: Lipid-lowering drugs decrease all-cause and cardiac mortality and CV events in CKD
G. V. Ramesh Prasad, MBBS, FRCPC
Ann Intern Med. 2012;157(10):JC5-5. doi:10.7326/0003-4819-157-10-201211200-02005
ACP Journal Club |  20 November 2012
Review: Intensive glucose control reduces surrogate, but not clinical, renal outcomes in type 2 diabetes
Eugene C. Corbett Jr., MD, MACP
Ann Intern Med. 2012;157(10):JC5-6. doi:10.7326/0003-4819-157-10-201211200-02006
ACP Journal Club |  20 November 2012
Fractional flow reserve–guided PCI reduced urgent revascularization at 7 months in coronary artery disease
Jay N. Cohn, MD
Ann Intern Med. 2012;157(10):JC5-9. doi:10.7326/0003-4819-157-10-201211200-02009
ACP Journal Club |  20 November 2012
Refusal of transfusions for cardiac surgery was not associated with shorter long-term survival
John Kepros, MD
Ann Intern Med. 2012;157(10):JC5-11. doi:10.7326/0003-4819-157-10-201211200-02011
ACP Journal Club |  16 October 2012
Meta-analysis: Lowering LDL-C levels using statins reduces major vascular events regardless of baseline risk
Meera Jain, MD; Mark Rosenberg, MD
Ann Intern Med. 2012;157(8):JC4-2. doi:10.7326/0003-4819-157-8-201210160-02002
ACP Journal Club |  16 October 2012
Intensive BP control and/or glucose control did not reduce microvascular events in hypertensive type 2 diabetes
Juan P. Brito, MD; Victor M. Montori, MD, MSc
Ann Intern Med. 2012;157(8):JC4-7. doi:10.7326/0003-4819-157-8-201210160-02007
ACP Journal Club |  16 October 2012
Hormonal contraceptives with ethinyl estradiol were associated with increased thrombotic stroke and MI
Jeff Andrews, MD, FRCSC
Ann Intern Med. 2012;157(8):JC4-9. doi:10.7326/0003-4819-157-8-201210160-02009
ACP Journal Club |  16 October 2012
Review: Quality improvement strategies reduce HbA1c, LDL cholesterol, and BP in diabetes
Sean F. Dinneen, MD; Máire O’Donnell, PhD
Ann Intern Med. 2012;157(8):JC4-11. doi:10.7326/0003-4819-157-8-201210160-02011
ACP Journal Club |  16 October 2012
QRISK2-2011 predicted cardiovascular disease in adult general practice patients
Kim Eagle, MD; Prashant Vaishnava, MD
Ann Intern Med. 2012;157(8):JC4-12. doi:10.7326/0003-4819-157-8-201210160-02012
ACP Journal Club |  16 October 2012
Various risk stratification schemes predict ischemic stroke and bleeding in atrial fibrillation
Brian F. Gage, MD, MSc; Ambar Andrade, MD
Ann Intern Med. 2012;157(8):JC4-13. doi:10.7326/0003-4819-157-8-201210160-02013
ACP Journal Club |  18 September 2012
Review: New oral anticoagulants reduced stroke and systemic embolism compared with warfarin in AF
Liviu Klein, MD, MS
Ann Intern Med. 2012;157(6):JC3-2. doi:10.7326/0003-4819-157-6-201209180-02002
ACP Journal Club |  18 September 2012
Review: Varenicline is better than bupropion but not nicotine patch for smoking abstinence in adults
Allan V. Prochazka, MD; Tanner J. Caverly, MD
Ann Intern Med. 2012;157(6):JC3-7. doi:10.7326/0003-4819-157-6-201209180-02007
ACP Journal Club |  18 September 2012
Short-term was less effective than long-term flecainide for preventing recurrent AF after cardioversion
D. George Wyse, MD, PhD, FRCPC, FACP
Ann Intern Med. 2012;157(6):JC3-9. doi:10.7326/0003-4819-157-6-201209180-02009
ACP Journal Club |  18 September 2012
Glargine did not reduce CV events more than standard care in patients with dysglycemia
Ellis Lader, MD
Ann Intern Med. 2012;157(6):JC3-10. doi:10.7326/0003-4819-157-6-201209180-02010
ACP Journal Club |  18 September 2012
Daily n-3 fatty acid supplements did not reduce CV events in high-risk patients with dysglycemia
Ellis Lader, MD
Ann Intern Med. 2012;157(6):JC3-11. doi:10.7326/0003-4819-157-6-201209180-02011
ACP Journal Club |  21 August 2012
Review: Varenicline for tobacco cessation does not increase CV serious adverse events
Paul Krebs, PhD; Scott E. Sherman, MD, MPH
Ann Intern Med. 2012;157(4):JC2-2. doi:10.7326/0003-4819-157-4-201208210-02002
ACP Journal Club |  21 August 2012
Review: Omega-3 fatty acid supplements provide no protective benefit in cardiovascular disease
Sharif A. Halim, MD; L. Kristin Newby, MD, MHS
Ann Intern Med. 2012;157(4):JC2-3. doi:10.7326/0003-4819-157-4-201208210-02003
ACP Journal Club |  21 August 2012
Warfarin and aspirin did not differ for death or stroke in heart failure and sinus rhythm
Tariq Ahmad, MD, MPH; G. Michael Felker, MD, MHS
Ann Intern Med. 2012;157(4):JC2-7. doi:10.7326/0003-4819-157-4-201208210-02007
ACP Journal Club |  21 August 2012
24- and 6-month dual antiplatelet therapy after coronary stenting did not differ for clinical outcomes
Brigitta C. Brott, MD; William B. Hillegass, MD, MPH
Ann Intern Med. 2012;157(4):JC2-9. doi:10.7326/0003-4819-157-4-201208210-02009
ACP Journal Club |  20 March 2012
Simvastatin reduced major vascular events at 5 years in at-risk patients; benefits were maintained at 11 years
Edward P. Havranek, MD
Ann Intern Med. 2012;156(6):JC3-5. doi:10.7326/0003-4819-156-6-201202210-02005
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)